FDA and Health Canada Approve OneTouch Vibe Plus Insulin Pump

December 20, 2016

Animas Corporation, a division of the Johnson & Johnson Diabetes Care Companies, has gained FDA clearance and Health Canada’s authorization for its OneTouch Vibe plus insulin pump and continuous glucose monitoring system for the treatment of patients age two and older living with diabetes.

The transmitter collects blood glucose readings from the sensor and sends them to the patient's insulin pump screen and compatible mobile device systems and app. — Cynthia Jessup

View today's stories